Biomet Again Underscores FCPA Risks In Life Sciences
In a recently issued 8-K, Biomet Inc., an Indiana-based medical device company, announced that the U.S. Department of Justice had extended the company's deferred prosecution agreement and monitorship relating to violations of...To view the full article, register now.
Already a subscriber? Click here to view full article